+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Sustainable Devices in Pharmaceutical Market by Type, Material Composition, End-use - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 197 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5967806
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Sustainable Devices in Pharmaceutical Market grew from USD 13.77 billion in 2023 to USD 16.21 billion in 2024. It is expected to continue growing at a CAGR of 18.73%, reaching USD 45.82 billion by 2030.

Sustainable devices in the pharmaceutical industry encompass eco-friendly and efficient solutions designed to reduce environmental impact while maintaining efficacy. The scope includes a range of devices such as biodegradable packaging, reusable delivery systems, and energy-efficient manufacturing equipment that adhere to environmental guidelines. The necessity for sustainable devices arises from growing regulatory pressure, heightened awareness of climate change, and consumer demand for green practices. These devices find applications across drug delivery, diagnostics, and packaging, serving as integral components in the lifecycle of pharmaceutical products. Key end-use sectors include pharmaceutical companies, healthcare institutions, and research labs. Market growth is fueled by technological advancements, increased investment in sustainability, and the rising demand for green pharmaceuticals. Companies are pursuing innovations in material science and energy efficiency to accelerate the adoption of sustainable devices. Opportunities abound in expanding partnerships with green tech firms and investing in research focused on recyclability and life-cycle assessment of devices. However, the market faces challenges, such as high initial costs, regulatory hurdles, and a lack of standardized practices for labeling and certifications. To overcome limitations, stakeholders must focus on policy advocacy, cost reduction through economies of scale, and cross-industry collaborations. Potential areas of innovation include the development of smart, energy-efficient manufacturing processes and the creation of new biodegradable polymers. The business landscape is dynamic, with startups entering the market and established firms enhancing their sustainable product lines. For sustained growth, companies must emphasize transparency, adopt circular economy principles, and incorporate consumer feedback into product development. As awareness expands, the market for sustainable pharmaceutical devices is poised for significant growth, provided stakeholders address challenges effectively and capitalize on emerging opportunities.

Understanding Market Dynamics in the Sustainable Devices in Pharmaceutical Market

The Sustainable Devices in Pharmaceutical Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Growing global consciousness about environmental issues
    • Increasing demand for sustainable devices across mobility and energy solutions
  • Market Restraints
    • High cost associated with the eco-friendly materials
  • Market Opportunities
    • Continuous innovations in green technology improve the efficiency and appeal of sustainable devices
    • Government supports for renewable energy sources and green technologies
  • Market Challenges
    • Technological limitations associated with sustainable devices

Exploring Porter’s Five Forces for the Sustainable Devices in Pharmaceutical Market

Porter’s Five Forces framework further strengthens the insights of the Sustainable Devices in Pharmaceutical Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Sustainable Devices in Pharmaceutical Market

External macro-environmental factors deeply influence the performance of the Sustainable Devices in Pharmaceutical Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Sustainable Devices in Pharmaceutical Market

The Sustainable Devices in Pharmaceutical Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Sustainable Devices in Pharmaceutical Market

The Sustainable Devices in Pharmaceutical Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Sustainable Devices in Pharmaceutical Market

The Sustainable Devices in Pharmaceutical Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Sustainable Devices in Pharmaceutical Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Amcor PLC, AptarGroup, Inc., Baxter International Inc., Becton, Dickinson and Company, Boston Scientific Corporation, Fresenius SE & Co. KGaA, GE HealthCare Technologies Inc., Interuniversity Microelectronics Centre, Johnson & Johnson Services, Inc., Medtronic PLC, Royal Philips, Siemens Healthineers AG, Stryker Corporation, Terumo Corporation, and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Sustainable Devices in Pharmaceutical Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Type
    • Diagnostic Devices
    • Drug Delivery Devices
    • Packaging Material
  • Material Composition
    • Biodegradable Material
    • Recyclable Plastics
    • Renewable Material
  • End-use
    • Homecare Settings
    • Hospital & Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing global consciousness about environmental issues
5.1.1.2. Increasing demand for sustainable devices across mobility and energy solutions
5.1.2. Restraints
5.1.2.1. High cost associated with the eco-friendly materials
5.1.3. Opportunities
5.1.3.1. Continuous innovations in green technology improve the efficiency and appeal of sustainable devices
5.1.3.2. Government supports for renewable energy sources and green technologies
5.1.4. Challenges
5.1.4.1. Technological limitations associated with sustainable devices
5.2. Market Segmentation Analysis
5.2.1. Type: Growing popularity of renewable energy devices coupled with the advancements in storage systems
5.2.2. End-use: Expansion of transportation & mobility with the adoption of sustainability solutions
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Sustainable Devices in Pharmaceutical Market, by Type
6.1. Introduction
6.2. Diagnostic Devices
6.3. Drug Delivery Devices
6.4. Packaging Material
7. Sustainable Devices in Pharmaceutical Market, by Material Composition
7.1. Introduction
7.2. Biodegradable Material
7.3. Recyclable Plastics
7.4. Renewable Material
8. Sustainable Devices in Pharmaceutical Market, by End-use
8.1. Introduction
8.2. Homecare Settings
8.3. Hospital & Clinics
9. Americas Sustainable Devices in Pharmaceutical Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Sustainable Devices in Pharmaceutical Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Sustainable Devices in Pharmaceutical Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Universal Electronics Inc. Unveils Cutting-Edge Sustainable Tech and Software for Smarter Living
12.3.2. Apple Pioneers Sustainability with Carbon-Neutral Apple Watch and Eco-Friendly Innovations
12.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET RESEARCH PROCESS
FIGURE 2. SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2023 VS 2030 (%)
FIGURE 9. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
FIGURE 11. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET DYNAMICS
TABLE 7. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY DRUG DELIVERY DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PACKAGING MATERIAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY BIODEGRADABLE MATERIAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY RECYCLABLE PLASTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY RENEWABLE MATERIAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. AMERICAS SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 22. ARGENTINA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 23. ARGENTINA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 24. ARGENTINA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 25. BRAZIL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 26. BRAZIL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 27. BRAZIL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 28. CANADA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 29. CANADA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 30. CANADA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 31. MEXICO SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 32. MEXICO SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 33. MEXICO SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 38. ASIA-PACIFIC SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 39. ASIA-PACIFIC SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 41. ASIA-PACIFIC SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 42. AUSTRALIA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 43. AUSTRALIA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 44. AUSTRALIA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 45. CHINA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 46. CHINA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 47. CHINA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 48. INDIA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 49. INDIA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 50. INDIA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 51. INDONESIA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 52. INDONESIA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 53. INDONESIA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 54. JAPAN SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 55. JAPAN SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 56. JAPAN SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 57. MALAYSIA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 58. MALAYSIA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 59. MALAYSIA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 60. PHILIPPINES SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 61. PHILIPPINES SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 62. PHILIPPINES SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 63. SINGAPORE SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 64. SINGAPORE SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 65. SINGAPORE SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 66. SOUTH KOREA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 67. SOUTH KOREA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 68. SOUTH KOREA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 69. TAIWAN SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 70. TAIWAN SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 71. TAIWAN SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 72. THAILAND SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 73. THAILAND SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 74. THAILAND SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 75. VIETNAM SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 76. VIETNAM SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 77. VIETNAM SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 82. DENMARK SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 83. DENMARK SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 84. DENMARK SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 85. EGYPT SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 86. EGYPT SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 87. EGYPT SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 88. FINLAND SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 89. FINLAND SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 90. FINLAND SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 91. FRANCE SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 92. FRANCE SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 93. FRANCE SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 94. GERMANY SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 95. GERMANY SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 96. GERMANY SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 97. ISRAEL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 98. ISRAEL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 99. ISRAEL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 100. ITALY SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 101. ITALY SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 102. ITALY SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 103. NETHERLANDS SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 104. NETHERLANDS SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 105. NETHERLANDS SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 106. NIGERIA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 107. NIGERIA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 108. NIGERIA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 109. NORWAY SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 110. NORWAY SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 111. NORWAY SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 112. POLAND SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 113. POLAND SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 114. POLAND SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 115. QATAR SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 116. QATAR SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 117. QATAR SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 118. RUSSIA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 121. SAUDI ARABIA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 122. SAUDI ARABIA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 123. SAUDI ARABIA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 124. SOUTH AFRICA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 126. SOUTH AFRICA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 127. SPAIN SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 128. SPAIN SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 129. SPAIN SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 130. SWEDEN SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 131. SWEDEN SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 132. SWEDEN SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 133. SWITZERLAND SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 134. SWITZERLAND SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 135. SWITZERLAND SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 136. TURKEY SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 137. TURKEY SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 138. TURKEY SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 139. UNITED ARAB EMIRATES SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 140. UNITED ARAB EMIRATES SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 141. UNITED ARAB EMIRATES SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 145. SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SHARE, BY KEY PLAYER, 2023
TABLE 146. SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Sustainable Devices in Pharmaceutical Market, which are profiled in this report, include:
  • 3M Company
  • Amcor PLC
  • AptarGroup, Inc.
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Fresenius SE & Co. KGaA
  • GE HealthCare Technologies Inc.
  • Interuniversity Microelectronics Centre
  • Johnson & Johnson Services, Inc.
  • Medtronic PLC
  • Royal Philips
  • Siemens Healthineers AG
  • Stryker Corporation
  • Terumo Corporation
  • Zimmer Biomet Holdings, Inc.

Methodology

Loading
LOADING...

Table Information